Zoetis Inc.

Key Statistics

Recent News

• Zoetis (ZTS) Stock Dips While Market Gains: Key Facts Zacks

  Zoetis (ZTS) closed the most recent trading day at $79.57, moving 2.25% from the previous trading session.

• Zoetis (ZTS) Stock Draws Fresh Price Target Split After Difficult Q1 Update Simply Wall St.

  Zoetis is back in focus as analysts recalibrate their price targets, with Citi cutting its view to US$112 from US$145 while other firms move to US$95 and US$115 after a sharp reset in sentiment. These

• PAHC Stock: What's Driving Phibro's Animal Health Growth Zacks

  Phibro Animal Health unit drove 74% of fiscal 2025 revenue, fueled by MFA, vaccines and global expansion, helping offset pressure in other businesses.

• Is PAHC Undervalued at 10x Earnings vs Peers? Zacks

  Phibro trades near 10x forward earnings vs higher peer multiples as strong Q3 beat, margin gains and 2026 guidance support a modest upside case.

• Chewy Earnings Are Unremarkable. They Could Have Been Worse. Barrons.com

  Shares of the pet supplies retailer rise after Chewy posts first-quarter adjusted earnings that meet expectations.

• Here’s What Analysts Are Saying About Zoetis Inc. (ZTS) Insider Monkey

  Zoetis Inc. (NYSE:ZTS) is one of the best healthcare stocks to buy with highest upside potential. Zoetis Inc. (NYSE:ZTS) received a rating update from Stifel on May 22. The firm cut the price target o

• Zoetis Lenivia Approval Tests Companion Animal Growth And Legal Concerns Simply Wall St.

  Zoetis (NYSE:ZTS) has received UK approval for Lenivia, a long acting monoclonal antibody therapy for osteoarthritis pain in dogs. The decision expands the company's monoclonal antibody portfolio in i

• Is IDEXX Laboratories Stock Underperforming the Nasdaq? Barchart

  IDEXX Laboratories has trailed the Nasdaq Composite over the past year, and analysts are fairly bullish on its future growth potential.